Pharmacogenomics of Morphine response in children with sickle cell disease (Pharmacogenetics of Morphine)

← Back to all studies

Pharmacogenomics of Morphine response in children with sickle cell disease (Pharmacogenetics of Morphine)

Health Condition: -
Health Impact Domain: -

Summary

-

Key Publications

-

Related Media

-

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of the Emergency Medical Services for Children Data Center award totaling $3,200,000 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.

PECARN is committed to making health care information accessible for everyone. Please contact melissa.laws@hsc.utah.edu if you encounter a document, such as an older PDF brochure or historical form, that has not been optimized for your screen reader. We consider these remediation requests a top priority and will provide an accessible version as soon as possible.